Canada - the Anthrax Vaccine (BioThrax) (W6369-20A009/A)

Description

Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: Generally only one firm has been invited to bid
Non-Competitive Procurement Strategy: Exclusive Rights
Comprehensive Land Claim Agreement: No
Vendor Name and Address:
Emergent BioDefense Operations Lansing LLC
3500 N Martin Luther King Jr Blvd
Lansing Michigan
United States
48906
Nature of Requirements:

Anthrax Vaccine (BioThrax)

W6369-20A009/A
Baird, Christa
Telephone No. - (403) 991-5231

Advance Contract Award Notice (ACAN):

An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre-identified supplier.

Definition of Requirement:

The Department of National Defence has a requirement for the supply of a firm quantity of 12,000 doses of Anthrax Vaccine for the prevention of disease caused by bacillus anthracis, and optional quantity of up to a maximum of 84,000 doses to be delivered over an 8 year period from date of contract award.

Criteria for Assessment of the Statement of Capabilities:

Any interested supplier must demonstrate by way of a statement of capabilities that its vaccine meets the following requirements:

a. Vaccine offered must be approved by a credible regulatory agency (i.e., Health Canada, FDA, EMEA, MHRA) for protection against Anthrax as pre-exposure prophylaxis.

b. If blood products are used in the production of the offered vaccine, it must be manufactured using only North American sourced blood products (e.g. plasma, albumin) so as to ensure the vaccine is Bovine Spongiform Encephalopathy (BSE)/Transmissible Spongiform Encephalopathy (TSE) free.

c. Supplier/manufacturer must demonstrate that they meet and are compliant with current Good Manufacturing Practices (cGMP).

d. Have a shelf life with a minimum of 42 months from the date of manufacture when stored at 2° to 8° C or above.

Justification for the Pre-Identified Supplier:

Emergent BioDefense Operations Lansing LLC, 3500 N Martin Luther King Jr Blvd, Lansing, Michigan, 48906 is the only known supplier of a licensed Anthrax Vaccine, for the prevention of disease caused by bacillus anthracis, trade name BioThrax®.

Government Contracts Regulations Exception:

The following exception to the Government Contracts Regulations is invoked for this procurement under subsection 6(d) - "only one person is capable of performing the work".

Term of Contract and Delivery:

Contract award to March 31, 2027.

The firm quantity must be delivered within 3 months of contract award.

The option quantity, if exercised, must be delivered within 26 weeks of written notice.

Suppliers' right to submit a statement of capabilities:

Suppliers who consider themselves fully qualified and available to provide the goods, services or construction services described in the ACAN may submit a statement of capabilities in writing to the contact person identified in this notice on or before the closing date of this notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.

Closing date for a submission of a statement of capabilities:

The closing date and time for accepting statements of capabilities is September 12, 2019 at 2:00 p.m. EDT.

Inquiries and submission of statements of capabilities

Inquiries and statements of capabilities are to be directed to:

Christa Baird, Supply Team Leader
Christa.baird@pwgsc.gc.ca

Delivery Date: Above-mentioned

You are hereby notified that the government intends to negotiate with one firm only as identified above. Should you have any questions concerning this requirement, contact the contracting officer identified above.

An Advance Contract Award Notice (ACAN) allows departments and agencies to post a notice, for no less than fifteen (15) calendar days, indicating to the supplier community that it intends to award a good, service or construction contract to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the requirements set out in the ACAN, the contracting authority may then proceed with the award. However, should a Statement of Capabilities be found to meet the requirements set out in the ACAN, then the contracting authority will proceed to a full tendering process.

Suppliers who consider themselves fully qualified and available to provide the services/goods described herein, may submit a statement of capabilities in writing to the contact person identified in this Notice on or before the closing date of this Notice. The statement of capabilities must clearly demonstrate how the supplier meets the advertised requirements.

The PWGSC file number, the contracting officer's name and the closing date of the ACAN must appear on the outside of the envelope in block letters or, in the case of a facsimile transmission, on the covering page.

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.

Opportunity closing date

12 September 2019

Value of contract

to be confirmed